23 June 2020
Publication of Prospectus
The following prospectus (the Prospectus) has been approved by the Financial Conduct Authority and is available for viewing:
Imperial Brands Finance PLC and Imperial Brands Finance Netherlands B.V.
€15,000,000,000 Debt Issuance Programme dated 23 June 2020
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8510Q_1-2020-6-23.pdf
A copy of the Prospectus has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Imperial Brands Finance PLC
James King, Senior Investor Relations Manager
121 Winterstoke Road
Bristol
BS3 2LL
England
Telephone: +44 (0) 758 105 2880
Email: james.king@impbrands.com
Election of home Member State under the Transparency Directive
Imperial Brands Finance Netherlands B.V. elects the United Kingdom as its home Member State for the purposes of the Transparency Directive (Directive 2004/109/EC, as amended).
DISCLAIMER ‑ INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
